drugset / Trial / NCT01183364
A Dose Escalation Study of STA-9090 and Docetaxel in Patients With Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
This is an open-label, Phase 1, dose-escalation study to determine the recommended doses of STA-9090 (ganetespib) and docetaxel for the treatment of subjects with solid tumor malignancies. The safety and tolerability of the treatment will also be evaluated.
Timeline
- Start
- 2010-07
- Primary completion
- 2013-03
- Completion
- 2013-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Docetaxel | Small molecule | — | Intravenous |
| Subject | Ganetespib | Small molecule | — | Intravenous |
Indications
No indication recorded.